The Estée Lauder Companies Inc. EL Moat

Key data

The moat

A woman who has used Clinique's three-step system since college rebuys it without comparing ingredient decks, and what she loses by switching is not performance but the certainty that the thing on her face will behave the way it did last month. That is the asset here: over 20 owned prestige trademarks, several continuously marketed since 1946, 1968 and 1994, distributed in roughly 150 countries through wholesale accounts plus about 1,600 freestanding stores, six of which carry brands at $1 billion or more of annual sales. Swap in Coty, Shiseido or Church & Dwight and that sentence breaks on every clause. Classify it as a brand moat, high confidence, with a thin secondary layer of shelf and counter access, since department store and specialty-multi doors are allocated to companies that can staff and merchandise them.

What the brand produces is price. Reported net sales rose 7% on price in fiscal 2024 and 2% in fiscal 2025 while volume fell 8% and then 10%. Gross margin of 75.5% in fiscal 2026 sits roughly 1,260 basis points above Coty's 62.9% in the same fiscal year. The premium is externally provable against Coty and against L'Oréal's 74.3%; the volume behind it is not holding.

Widening or narrowing

The gross margin sequence runs 79.4%, 77.2%, 75.7%, 71.3%, 71.7%, 74.0%, 75.5% across fiscal 2017, 2019, 2022, 2023, 2024, 2025 and 2026. The recovery is real and three periods long, but it arrives on a revenue base of $15.05 billion against $17.74 billion in fiscal 2022, with fragrance up to $2.78 billion and skin care down to $7.34 billion from $9.89 billion. Mix, not pricing power, explains much of the margin rebuild, because fragrance carries the luxury price architecture and skin care carried the volume. Operating margin tells the harsher version: 17.9%, 9.5%, 6.2%, 8.0%, 11.1%.

In prestige beauty the fat slice of the profit pool belongs to whoever owns the trademark, since the liquid inside costs little. The company holds that slice and still converted it into 4.1% return on invested capital on the vendor's calculation, against 16.0% in fiscal 2022, because the share of the pool going to retailers, Douyin and the advertising platforms keeps rising.

The overrated case is simple and documented. The company wrote down $773 million of TOM FORD trademark value and $75 million of Too Faced trademark value in the December 2024 quarter, plus $13 million zeroing Too Faced goodwill. Six consecutive quarters of China share gain and a number one prestige ranking were stated on the August 2026 call and remain company claims, asserted, not proven, and they sit against Asia Pacific sales falling from $5.49 billion in fiscal 2021 to $3.75 billion in fiscal 2026. Verdict: narrowing.

What breaks it, and who

L'Oréal is the pressure that matters. It grew 4.0% like for like in calendar 2025 on €44.05 billion of sales and earned a 20.2% operating margin, roughly double this company's 11.1%, which funds more media and more launches per brand every year the gap persists.

Channel shift is the second break, and part of it is self-inflicted. The Ordinary, acquired outright in 2024, is one of the three fastest-growing brands in the portfolio and sells on published-ingredient logic at low price points, which trains the same consumer who used to pay for Clinique to ask what the markup buys.

L'Oréal is the specific number one; this company and LVMH beauty contest second place. The read changes if fiscal 2027 brings a second year of positive organic growth with Asia Pacific sales flat or up, or if another trademark impairment lands at the April testing date.

Closing thoughts

The moat is real but conditional, and narrowing. Pricing power survives in fragrance and in La Mer, and it has thinned badly in makeup and mass-adjacent skin care, where volume fell 8% then 10% while price rose. The one checkable thing is Asia Pacific net sales, which have declined every fiscal year since 2021 and dropped 17% in fiscal 2026 even as management claimed six quarters of share gain; that contradiction resolves in the next two filings. The moat strengthens if Asia Pacific revenue stops declining while gross margin holds above 75%, and weakens if margin recovery continues to rest on fragrance mix while skin care sales fall below $7 billion.